Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou, Jiancheng Lv, Hao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 224

Showing 1-25 of 224 citing articles:

Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 172
ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis
Hao Yu, Xiao Yang, Jinyuan Tang, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 23, pp. 27-41
Open Access | Times Cited: 139
WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis
Zhi‐Xuan Li, Zi‐Qi Zheng, Pan-Yang Yang, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1137-1151
Open Access | Times Cited: 123
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 118
METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma
Yuzhou Chang, Ruichao Chai, Bo Pang, et al.
Cancer Letters (2021) Vol. 511, pp. 36-46
Closed Access | Times Cited: 109
Recent advances in droplet microfluidics for single-cell analysis
Zhenqi Jiang, Haoran Shi, Xiaoying Tang, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 159, pp. 116932-116932
Closed Access | Times Cited: 108
YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance
Yu Sun, Dan Dong, Yuhong Xia, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 89
Epigenetic modification of m6A regulator proteins in cancer
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer
Rui Sun, Lin Yuan, Yi Jiang, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 833-848
Open Access | Times Cited: 47
The role of tumor-associated macrophages in tumor immune evasion
Ruizhe Huang, Ting Kang, Siyu Chen
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 44
Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma
Yin Li, Jie Gu, Fengkai Xu, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 4
Closed Access | Times Cited: 132
The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells
Dongling Zou, Lei Dong, Chenying Li, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 130
Principles of RNA methylation and their implications for biology and medicine
Yujia Zhou, Ying Kong, Wenguo Fan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110731-110731
Open Access | Times Cited: 100
Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer
Pengju Gong, You-Cheng Shao, Yan Yang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 96
Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors
Simona Selberg, Neinar Seli, Esko Kankuri, et al.
ACS Omega (2021) Vol. 6, Iss. 20, pp. 13310-13320
Open Access | Times Cited: 90
METTL16 promotes cell proliferation by up‐regulating cyclin D1 expression in gastric cancer
Xiao‐Kun Wang, Ya‐Wei Zhang, Chunming Wang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 14, pp. 6602-6617
Open Access | Times Cited: 81
CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner
Xin Liu, Yunze Liu, Zhao Liu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 78
Epigenetic regulation in fibrosis progress
Taixiong Xue, Xingyu Qiu, Hongyao Liu, et al.
Pharmacological Research (2021) Vol. 173, pp. 105910-105910
Closed Access | Times Cited: 71
M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression
Dongming Lv, Shirong Ding, Li Zhong, et al.
Oncogene (2022) Vol. 41, Iss. 12, pp. 1727-1741
Closed Access | Times Cited: 45
Effects of writers, erasers and readers within miRNA‐related m6A modification in cancers
Huiru Feng, Xiaofei Yuan, Shuting Wu, et al.
Cell Proliferation (2022) Vol. 56, Iss. 1
Open Access | Times Cited: 39
m6A‐Dependent Modulation via IGF2BP3/MCM5/Notch Axis Promotes Partial EMT and LUAD Metastasis
Xia Yang, Qiaorui Bai, Weizhong Chen, et al.
Advanced Science (2023) Vol. 10, Iss. 20
Open Access | Times Cited: 30
Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma
Xiaowei Liang, Hongwei Gao, Jian Xiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
The involvement of RNA N6‐methyladenosine and histone methylation modification in decidualization and endometriosis‐associated infertility
Xiang Lin, Yongdong Dai, Weijia Gu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 11
RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy
Huanxiang Chen, Hongyang Liu, Chenxing Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 8
Regulatory roles of N6-methyladenosine (m6A) methylation in RNA processing and non-communicable diseases
Faiz Ali Khan, Bernard Nsengimana, Usman Ayub Awan, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top